In these studies we sought to evaluate the effect of the same TLR signaling inhibitor, C10, on human MCF-7 breast cancer cells that exhibit high constitutive levels of TLR3 and Wnt5a RNA. This evidence concerns the gene WNT5A and breast carcinoma.